Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

Completed

Conditions studied: Antiretroviral Toxicity

In brief

SMARTT will estimate the incidence of conditions and diagnoses potentially related to in utero exposure to antiretroviral therapy and/or exposure in the first two months of life among children born of HIV-infected mothers.

Key facts

Study ID
NCT01310023
Run by
Harvard School of Public Health (HSPH)
People needed
5169
Starts
2007-03-01
Expected to finish
2025-05-31
Last updated by the study team
2025-06-27

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.